TABLE 3.

Immune-related adverse events (irAEs) associated with neoadjuvant immunotherapy

irAE	Any (%)	Grade 3 or 4 (%)
Arthralgia	3 (17.6)	0 (0)
Abdominal pain	1 (5.8)	0 (0)
Rash	2 (11.8)	0 (0)
Pruritus	3 (17.6)	0 (0)
Fatigue	2 (11.8)	0 (0)
Diarrhea	3 (17.6)	0 (0)
Hypothyroidism	2 (11.8)	0 (0)
Pneumonitis	1 (5.8)	1 (5.8)
Transaminitis	2 (11.8)	1 (5.8)
Infusion reaction	1 (5.8)	1 (5.8)
Any event leading to delay in therapy	1 (5.8)	1 (5.8)

irAE, immune-related adverse event as graded by CTACE v4.0